Tag: officer

WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time.

LUXEMBOURG, July 21, 2025 (GLOBE NEWSWIRE) -- On Thursday, July 24, 2025, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the second quarter 2025. A press release and presentation will be available on Altisource’s website in the Investor Relations section.

A Star-Studded Cast of Cultural Icons Heads to the Hamptons for the Ultimate Summer Fling 

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor blood-derived, cell-based allogeneic therapies for the affordable treatment of blood and solid cancers, is pleased to announce the successful completion of dose level 1 for its first-in-human Phase I dose-escalation clinical trial (NCT05302037) (“ANGELICA Trial”) for four late stage cancer patients and is scheduled to start dose level 2 of the ANGELICA Trial in third quarter of 2025.

High-integrity carbon removal credits will be used to support buyer’s decarbonization and to mitigate corporate travel emissions

SAINT-BRUNO-DE-MONTARVILLE, Quebec, July 21, 2025 (GLOBE NEWSWIRE) -- Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) will release its results for the first quarter ended June 14, 2025, after market close on Thursday, July 24, 2025. A conference call to discuss these results will be held on Friday, July 25, 2025 at 9:30 a.m. (Eastern Time).